Mechanism of Action of Exenatide
Introduction Exenatide is an incretin-based antidiabetic drug classified as a glucagon-like peptide-1 (GLP-1) receptor agonist. It is used in the management of type 2 diabetes mellitus to improve glycemic control, particularly in patients with inadequate response to oral antidiabetic agents. Exenatide is exam-relevant because it mimics endogenous GLP-1, enhances glucose-dependent insulin secretion, promotes weight loss, … Read more